These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4051899)

  • 21. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 22. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 25. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid-lowering therapy and its effect on atherosclerosis.
    Thompson GR
    Postgrad Med J; 1989; 65 Suppl 1():S22-5. PubMed ID: 2695906
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperlipidemia.
    Kreisberg RA
    Curr Ther Endocrinol Metab; 1997; 6():509-19. PubMed ID: 9174798
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid disorders: applying new guidelines to your older patients.
    Leaf DA
    Geriatrics; 1994 May; 49(5):35-41. PubMed ID: 8174939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of lipid metabolism disorders in the elderly].
    Mizera W; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lipid lowering in transplantation.
    Wierzbicki AS
    Int J Clin Pract; 1999; 53(1):54-9. PubMed ID: 10344068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dyslipidemia: what every physician should keep in mind].
    Jambart S
    J Med Liban; 1993; 41(3):139-42. PubMed ID: 7799414
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR
    Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dyslipidemias].
    Spoto S; Navajas Martinez MF; Costantino S
    Clin Ter; 2003; 154(1):65-9. PubMed ID: 12854288
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of hyperlipidemia: diet and drugs are complementary to each other].
    Olsson A
    Lakartidningen; 1989 Feb; 86(5):316-7. PubMed ID: 2915581
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacologic treatment of lipid metabolism disorders].
    Gmiński J
    Wiad Lek; 1996; 49(7-12):173-81. PubMed ID: 9214849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.